HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors-Reference-Cited by-同舟云学术

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

Published:2012-07-06 Issue:7 Volume:7 Page:e39652
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cento Valeria,Mirabelli Carmen,Salpini Romina,Dimonte Salvatore,Artese Anna,Costa Giosuè,Mercurio Fabio,Svicher Valentina,Parrotta Lucia,Bertoli Ada,Ciotti Marco,Di Paolo Daniele,Sarrecchia Cesare,Andreoni Massimo,Alcaro Stefano,Angelico Mario,Perno Carlo Federico,Ceccherini-Silberstein Francesca

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Accessed 2012 Jun 15.,2011

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958–965.;MP Manns,2001

3. Outcome of sustained virological responders with histologically advanced chronic hepatitis C.;TR Morgan,2010

4. Diagnosis, management, and treatment of hepatitis C: an update.;MG Ghany,2009

5. Advances in therapy for chronic hepatitis C. Clin Liver Dis;MW Fried,2001

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

3. Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis;Nature Communications;2023-11-17

4. Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases;Cells;2023-01-25

5. Meet the Regional Editor;Current Enzyme Inhibition;2022-03